⌘K

Home/Filings/4/A/0001567619-21-021040

4/A//SEC Filing

BURGER DENIS R 4/A

Accession 0001567619-21-021040

CIK 0000882361other

View on SEC.gov Company Profile

Filed

Nov 22, 7:00 PM ET

Accepted

Nov 23, 3:32 PM ET

Size

7.2 KB

Accession

0001567619-21-021040

Insider Transaction Report

Form 4/AAmended

Period: 2021-11-19

Aptose Biosciences Inc.APTO

Director

Transactions

Exercise/Conversion
Director Stock Option (Right to Buy)
2021-11-19−5,417→ 0 total
Exercise: $2.04From: 2011-11-29Exp: 2021-11-29→ Common Shares (5,417 underlying)
Exercise/Conversion
Common Shares
2021-11-19$2.04/sh+5,417$11,051→ 21,671 total

Footnotes (1)

[F1]Converted from Canadian exercise price of C$2.58 using an exchange rate of C$1.2639 = US$1.00.

Documents

1 file

4
doc1.xml
FORM 4/A

Issuer

Aptose Biosciences Inc.

CIK 0000882361

Entity typeother

Related Parties

1

filerCIK 0001239414

Filing Metadata

Form type: 4/A
Filed: Nov 22, 7:00 PM ET
Accepted: Nov 23, 3:32 PM ET
Size: 7.2 KB

View on SEC.gov